These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 32380740)

  • 21. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of Bacterial Extracellular Vesicles and Identification of Their Protein Cargo.
    Garcia RA; Aragoneses-Cazorla G; Lerma L; Prados-Rosales RC; Luque-Garcia JL
    Methods Mol Biol; 2023; 2652():285-292. PubMed ID: 37093483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
    Domalaon R; Idowu T; Zhanel GG; Schweizer F
    Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotransformation of Vancomycin Overcomes the Intrinsic Resistance of Gram-Negative Bacteria.
    Fernandes MM; Ivanova K; Hoyo J; Pérez-Rafael S; Francesko A; Tzanov T
    ACS Appl Mater Interfaces; 2017 May; 9(17):15022-15030. PubMed ID: 28393523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outer Membrane Vesicles.
    McBroom AJ; Kuehn MJ
    EcoSal Plus; 2005 Nov; 1(2):. PubMed ID: 26443511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Contribution of Membrane Vesicles to Bacterial Pathogenicity in Cystic Fibrosis Infections and Healthcare Associated Pneumonia.
    Vitse J; Devreese B
    Front Microbiol; 2020; 11():630. PubMed ID: 32328052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatible bacteria-derived vesicles show inherent antimicrobial activity.
    Schulz E; Goes A; Garcia R; Panter F; Koch M; Müller R; Fuhrmann K; Fuhrmann G
    J Control Release; 2018 Nov; 290():46-55. PubMed ID: 30292423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the spread of antibiotic-resistant bacteria.
    Rao GG
    Drugs; 1998 Mar; 55(3):323-30. PubMed ID: 9530540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eco-evolutionary feedbacks mediated by bacterial membrane vesicles.
    Zlatkov N; Nadeem A; Uhlin BE; Wai SN
    FEMS Microbiol Rev; 2021 Mar; 45(2):. PubMed ID: 32926132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.
    Kaye KS; Pogue JM
    Pharmacotherapy; 2015 Oct; 35(10):949-62. PubMed ID: 26497481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of Global Antibiotic Resistance.
    Morehead MS; Scarbrough C
    Prim Care; 2018 Sep; 45(3):467-484. PubMed ID: 30115335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
    Gootz TD
    Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gram-negative and Gram-positive bacterial extracellular vesicles.
    Kim JH; Lee J; Park J; Gho YS
    Semin Cell Dev Biol; 2015 Apr; 40():97-104. PubMed ID: 25704309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antimicrobial resistance after antibiotic use in animals--impact on human health].
    Sundsfjord A; Sunde M
    Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2457-61. PubMed ID: 19096469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel pathway for outer membrane protein biogenesis in Gram-negative bacteria.
    Jeeves M; Knowles TJ
    Mol Microbiol; 2015 Aug; 97(4):607-11. PubMed ID: 26059329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
    Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
    Tzialla C; Borghesi A; Pozzi M; Stronati M
    Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
    Briers Y; Lavigne R
    Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.